Drug Profile
Cystic fibrosis gene therapy
Alternative Names: Compacted DNA; DNA nanoparticle gene therapy; Plasmid DNA vector expressing cystic fibrosis transmembrane geneLatest Information Update: 19 Sep 2011
Price :
$50
*
At a glance
- Originator Copernicus Therapeutics
- Class Gene therapies
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cystic fibrosis
Most Recent Events
- 19 Sep 2011 No development reported - Phase-I/II for Cystic fibrosis in USA (Intranasal)
- 19 Sep 2011 No development reported - Preclinical for Cystic fibrosis in USA (Intrapulmonary)
- 25 Mar 2008 Clinical development is ongoing